$8.22
+0.72 (+9.60%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+288.2% upside
Low Target
$24.67
Average Target
$31.91
High Target
$44.05
Current Price
$8.22
Current
$8.22
$8.22
Target
$31.91
$31.91
$24.67
$31.91 avg
$44.05
Scenario Analysis
Bear Case
$24.67
200.1%
Low target
Base Case
$31.91
+288.2%
Avg target
Bull Case
$44.05
+435.9%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$35.11
-76.6% from high
52-Week Low
$18.59
+-55.8% from low
Target vs 52W High
$31.91
-9.1% vs high
Next Earnings Report
Mar 2, 2026 · After Market Close
14d
until earnings
EPS Est: $-3.96
Earnings in 14 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 37 | 68% | $257.58 | +15.3% |
| AMGN | Hold | 41 | 54% | $190.87 | -50.3% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.8% |
| VRTX | Strong Buy | 39 | 77% | $438.34 | -8.3% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -90.2% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -68.8% |
| INSM | Strong Buy | 27 | 93% | $143.40 | -4.3% |
| BIIB | Hold | 42 | 48% | $91.45 | -54.5% |